Oliver Tracie 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Oliver Tracie
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-01-05$33.89/sh−74$2,508→ 136,501 total - Award
Common Stock
2024-01-04+75,000→ 136,575 total
Footnotes (4)
- [F1]Represents shares underlying restricted stock units with a grant date 01/04/24, which will vest in four equal annual installments.
- [F2]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F3]Partial disposition of RSUs to satisfy tax withholding obligations.
- [F4]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.